OCT 1, 2026 · JOURNAL ARTICLE
Aberrant Glycosylation in Cancer: From Immune Checkpoint Mechanisms to Glycan-Targeted Therapeutics
Glycoscience & Therapy
Aberrant glycosylation is a recurrent feature of cancer that can alter receptor signaling, cell adhesion, immune recognition, and therapeutic response. These effects arise from coo